Featured White Papers
- Hosted CRM comparison guide (Inside CRM)
- Hosted CRM buyer's guide (Inside CRM)
- Don't miss this enterprise mobility Webcast! (TechRepublic)
Health Care Industry
Industry: Email Alert RSS FeedButterbur, a herbal remedy, attenuates adenosine monophosphate induced nasal responsiveness in seasonal allergic rhinitis - Brief Article
Alternative Medicine Review, Nov, 2003 by DK Lee, IJ Carstairs, K Haggart
BACKGROUND: Butterbur (BB) or Petasites hybridus, a herbal remedy, exhibits in vitro inhibition of cysteinyl leukotriene biosynthesis. However, no placebo-controlled studies have been performed to evaluate the effectiveness of BB on objective outcomes such as nasal provocation testing in seasonal allergic rhinitis (SAR).
METHODS: Twenty patients with grass-pollen-sensitized SAR were randomized in a double-blind, cross-over manner to receive for 2 weeks either BB 50 mg twice daily or placebo (PL) twice daily during the grass pollen season. Nasal adenosine monophosphate (AMP) challenge (the primary outcome) was administered as a single 400 mg/mL dose after each randomized treatment. RESULTS: Spontaneous recovery following AMP challenge (area under the response time profile curve as % x min+/-SEM) was significantly attenuated (P=0.028) with BB (584+/-289) compared to PL (1438+/-240); mean difference: 854 (95% CI 95-1614), and the maximum % peak nasal inspiratory flow reduction from baseline following AMP challenge was significantly blunted (P=0.036) with BB (30+/-4) compared to PL (43+/-5): mean difference: 13 (95% CI 1-25). CONCLUSIONS: BB exhibited protection against AMP-induced nasal responsiveness during the grass pollen season in sensitized patients. This in turn may explain its potential clinical efficacy in patients with SAR.
COPYRIGHT 2003 Thorne Research Inc.
COPYRIGHT 2003 Gale Group